市场调查报告书
商品编码
1470847
全球放射治疗市场:按产品类型、治疗、应用和最终用户 - 预测 2024-2030Radiotherapy Market by Product (Hardware, Software & Service), Type (External Beam Radiotherapy/Teletherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), Procedure, Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年全球放射治疗市场规模为66.4亿美元,2024年达70.3亿美元,预计2030年将达到100.1亿美元,复合年增长率为6.04%。
放射治疗领域是一个医疗和保健产业,利用放射线来治疗方法癌症和一些非恶性疾病。它照射X射线、伽玛射线、带电粒子束等高能量射线,主要破坏癌细胞、抑制增生、缓和症状。世界上越来越多地采用放射疗法来治疗癌症,以及对微创治疗的日益偏好正在影响放射治疗世界的发展。相较之下,高昂的治疗成本、训练有素的专业人员有限以及与辐射暴露相关的风险限制了放射治疗在全世界的使用。然而,一些供应商正在致力于研究和开发以克服这些问题。此外,全球放射治疗设备的技术进步和改进以及癌症治疗机器人放射治疗全球系统的引入为开发和销售尖端设备提供了商机。
主要市场统计 | |
---|---|
基准年[2023] | 66.4亿美元 |
预测年份 [2024] | 70.3亿美元 |
预测年份 [2030] | 100.1亿美元 |
复合年增长率(%) | 6.04% |
向产品肿瘤部位提供高剂量辐射的硬体製造过程的进步
硬体包含用于提供世界放射治疗的所有有形元素。其中包括直线加速器、近距离放射治疗、质子治疗、电脑刀系统等。软体服务部分是指用于规划治疗通讯协定、模拟辐射剂量以及管理患者资料和分析的平台。服务包括各种支援功能,包括设备维护、培训、技术支援和咨询。相较之下,硬体提供了提供治疗的物理手段,而软体和服务则确保精确定位、剂量规划和无缝操作。
体外放射治疗世界/远距治疗的目标是肿瘤外和大肿瘤,因此消费者更喜欢外照射。
外束放射治疗 (EBRT)/远距治疗是一种常见的放射治疗形式,其中放射线来自患者体外并传递到癌症部位。传统的Cobalt-60远端医疗装置为癌症治疗提供连续旋转放射治疗,是一种具有更深穿透能力的高效能装置。 LINAC 向患者的肿瘤部位发送高能量 X 射线,破坏癌细胞的遗传物质并抑制其生长。传统的线性加速器使用微波技术来加速电子,然后与重金属目标碰撞,产生高能量 X 射线。电脑刀断层放射治疗使用机械臂从多个角度照射肿瘤,达到精准治疗。模组系统可调节辐射剂量,以尽量减少对健康组织的影响。伽玛刀向受影响区域提供精确剂量的辐射,减少对健康脑组织的损害。 MRI 直线加速器使临床医生能够即时观察正在治疗的肿瘤并根据需要调整治疗。立体定位高级 Electron/Cobalt-60 直线加速器从多个角度提供高剂量辐射,在小区域内进行精确治疗,最大限度地减少对周围健康组织的影响。粒子治疗系统使用带电粒子精确瞄准癌细胞,可能最大限度地减少对周围健康组织的辐射剂量,并降低副作用的风险。内部放射治疗/近距离放射治疗将高剂量的放射直接传送到癌症部位及其附近,而不会伤害周围的健康组织。它最常被选择用于治疗局部癌症,例如前列腺癌和子宫颈癌。后荷机旨在减少辐射医疗工作者的辐射暴露,加强病人安全政策并提高治疗准确性。施用器是一种设计用于帮助将放射源定位在患者体内的治疗部位的装置。术中放射治疗 (IORT) 系统是手术期间用于局部癌症治疗的先进放射治疗设备。种子是一种含有放射性物质的小型装置。当小心地植入癌组织时,这些种子可以将辐射直接传递到肿瘤,从而最大限度地减少对周围健康组织的损害。
碘苯胍 (i-131) 是一种被某些神经组织选择性吸收的分子。这种独特的特性使其成为诊断和治疗神经内分泌肿瘤的宝贵工具。由于其伽马射线特性,铼 186 同位素为医疗保健专业人员提供了一种利用医学成像技术追踪患者治疗结果的典范方法,使先进医学更进一步。 Samarium-153 具有双重能力:β 粒子可瞄准并摧毁癌细胞,伽马射线发射可促进生物分布的成像和追踪。
提升外束放射治疗的世界,简化手术流程并提升病患舒适度
体外照射疗法(EBRT)是用于治疗各种癌症的最常见的治疗方法。 3D 适形放射治疗可有效治疗多种类型的癌症,并因其准确性和最大限度减少副作用的能力而受到高度评价。影像导引放射治疗(IGRT)是一种先进的放射治疗,在治疗过程中涉及影像技术。强度调控放射治疗(IMRT) 优化放射治疗光束以配合肿瘤的形状,使其能够为癌症的不同部位提供不同强度的放射。粒子疗法是一种独特的治疗方法,它使用带电原子粒子向其穿过的组织传递低剂量,将能量集中在精确的点上。立体定位治疗可以向小而明确的肿瘤提供高剂量,特别是在大脑和其他区域,同时最大限度地减少对邻近正常组织的辐射,从而减少潜在的副作用。注射疗法在放射治疗领域,放射性物质被直接注射到体腔或膀胱中以治疗表浅癌症。近距离放射治疗涉及将放射源放置在肿瘤内部或旁边,确保高剂量的辐射,同时不伤害健康组织。高剂量率 (HDR) 近距离放射治疗旨在消灭癌细胞,同时最大限度地减少对周围健康组织的暴露和损害。 LDR 近距离放射治疗广泛用于治疗多种类型的癌症,包括子宫颈癌、摄护腺癌和眼部癌。脉衝剂量率 (PDR) 近距离放射治疗涉及在限时放射週期内以脉衝方式提供辐射,通常每小时一次。该技术旨在最大限度地向肿瘤输送剂量,同时保护周围的健康组织。在静脉注射放射治疗领域,液体放射性物质会经由静脉注射到体内。这种治疗通常用于已扩散的癌症。在口腔放射治疗领域,放射性物质以锭剂或液体形式摄取。用于治疗甲状腺癌等。全身性治疗使用在全身循环的放射性药物,适用于治疗已扩散到骨骼或身体其他部位的癌症。
应用:扩大放射治疗在全世界妇科癌症的应用
放射治疗在乳癌治疗中发挥重要作用,可显着降低手术后乳房内復发的风险。在子宫颈癌的治疗中,放射治疗通常是单独使用或与化疗合併使用。世界对放射治疗的需求高度依赖癌症的分期和定位。结直肠癌治疗中的放射治疗用于在手术前缩小肿瘤,并在手术后杀死剩余细胞。放射线治疗通常用于治疗各种类型的妇科癌症。根据癌症的类型和阶段,放射可用作主要治疗、辅助性治疗或安宁疗护。放射治疗在头颈癌的治疗中非常重要,并且经常与手术和化疗结合使用。肺癌放射治疗是一种主要的治疗方法。儘管阴茎癌很少见,但放射线治疗通常用作主要或辅助治疗。放射治疗对于局部前列腺癌的根治性非常有效。相较之下,由于併发症较少、局部控制和存活率较高,放射治疗较常用于妇科癌症。
最终用户:放射治疗领域在为癌症患者提供全面护理的医院服务中发挥着重要作用。
该医院为癌症患者提供全面的护理,包括诊断和治疗服务。将放射治疗作为医院内的综合服务提供将有助于更好地协调护理,从而改善患者的预后。独立的世界放射治疗中心是一家为癌症患者提供放射治疗的专业诊所。这些中心为患者提供更个人化和便利的照护。儘管这些设施可能提供部分服务,但医院通常能够提供更有效率、以患者为中心的放射治疗世界。医院通常提供更广泛的服务,可以为患有多种健康问题的患者提供全面的护理。另一方面,独立的世界放射治疗中心提供了一种更以患者为中心的方法,并且受到只寻求放射治疗世界的患者的青睐。
区域洞察
放射治疗在美洲的全球普及是由多种因素推动的,主要是癌症发生率的增加和对非侵入性治疗方法的偏好。 3D 适形放射治疗世界 (3D CRT) 和强度调控放射治疗世界 (IMRT) 等先进技术正在推动该市场的成长。同时,政府针对癌症预防和控制的措施也是这一市场扩张的主要因素。在欧洲、中东和非洲地区,癌症发生率的上升增加了全世界对放射治疗的需求。由于该地区观察到的癌症病例种类繁多,放射治疗成为首选的治疗解决方案,可以提供有针对性的有效治疗结果。全球创新放射治疗设备的监管核准、普及的癌症研究和坚实的医疗保健框架进一步增强了市场。在亚太地区,由于癌症发生率上升,全球放射治疗市场正在迅速扩大。一些国家的癌症发生率很高,这增加了对有效治疗方法,包括放射治疗领域。随着早期诊断意识的提高、癌症治疗机会的增加以及该领域的技术进步,该领域的成长得到了放大。亚太地区的新兴国家也大力投资医疗基础设施,进一步推动放疗在全球的采用。
FPNV定位矩阵
FPNV定位矩阵对于评估全球放射治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对全球放射治疗市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 全球放射治疗市场的市场规模和预测是多少?
2.在全球放射治疗市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.全球放射治疗市场的技术趋势和法规结构是什么?
4.全球放射治疗市场主要厂商的市场占有率为何?
5.进入全球放射治疗市场的合适模式和策略手段是什么?
[196 Pages Report] The Radiotherapy Market size was estimated at USD 6.64 billion in 2023 and expected to reach USD 7.03 billion in 2024, at a CAGR 6.04% to reach USD 10.01 billion by 2030.
Radiotherapy comprises businesses in the medical and healthcare sectors that harness radiation as a mode of treatment, typically for cancer and some non-malignant conditions. It involves deploying high-energy radiation, such as X-rays, gamma rays, and charged particles, primarily destroying cancerous cells, minimizing their growth, and reducing symptoms in palliative cases. The growing adoption of radiotherapy procedures for cancer treatment and rising preference for minimally invasive procedures influence the development of radiotherapy. In contrast, high treatment costs, limited availability of trained professionals, and risks associated with radiation exposure are restricting the utilization of radiotherapy. However, several vendors are working and investing in R&D to overcome these issues. Furthermore, technological advancements and improvements in radiotherapy devices and the introduction of robotic radiotherapy systems for cancer treatment are opportunities for businesses to create and market cutting-edge devices.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.64 billion |
Estimated Year [2024] | USD 7.03 billion |
Forecast Year [2030] | USD 10.01 billion |
CAGR (%) | 6.04% |
Product: Advancements in hardware manufacturing process as it provide high radiation doses to the tumor site
The hardware encapsulates all the tangible elements employed in administering radiotherapy treatment. These include linear accelerators, brachytherapy devices, proton therapy, and cyber knife systems. The software and service segment refers to the platforms used to plan treatment protocols, simulate radiation doses, and manage patient data and analytics. Services encompass various support functions, including equipment maintenance, training, technical support, and consulting. In comparison, the hardware provides the physical means to deliver treatment, while software & service ensure precise targeting, dose planning, and seamless operation.
Type: Consumer preference for external beam radiotherapy/teletherapy as they target tumor from outside and large tumors
External beam radiotherapy (EBRT)/ teletherapy is a common form of radiation treatment where the radiation originates outside the patient and is directed toward the cancer site. Conventional cobalt-60 teletherapy units provide continuously rotating radiation therapy for cancer treatment and are highly efficient with deeper penetration capabilities. Linear accelerators (LINACs) deliver high-energy X-rays to the patient's tumor region, damaging the cancerous cells' genetic material and disrupting their growth. Conventional linear accelerators utilize microwave technology to accelerate electrons before colliding them with a heavy metal target, thus generating high-energy X-rays. Cyberknife tomotherapy allows precision treatment through a robotic arm that delivers multiple angles of radiation to a tumor. The system modulates the radiation dose, minimizing the impact on healthy tissue. Gamma knife has exact doses of radiation to the affected area, reducing damage to healthy brain tissues. MRI Linac allows clinicians to visualize the tumor in real-time during treatment and adapt therapy as needed. Stereotactic advanced electron/cobalt-60 linear accelerators deliver high doses of radiation from multiple angles to treat a small area with pinpoint accuracy, minimizing the impact on surrounding healthy tissues. Particle therapy systems use charged particles to target cancer cells precisely, minimizing the radiation dose to nearby healthy tissue and potentially reducing the risk of side effects. Internal beam radiotherapy/Brachytherapy involves radiation delivery directly into and near the cancer site, providing a high radiation dose while sparing surrounding healthy tissues. It's often the top choice for treating localized cancers such as prostate and cervical cancers. Afterloaders aim to reduce exposure to radiation health professionals, enhancing policies for patient safety and increasing treatment precision. Applicators are designed instruments intended to aid in positioning the radiation sources into the treatment site in a patient's body. Intraoperative radiation therapy (IORT) systems are advanced radiotherapeutic devices used during surgeries for localized cancer treatment. Seeds are tiny devices that encase radioactive materials. When carefully implanted into cancerous tissues, these seeds can deliver radiation directly to the tumor, minimizing damage to nearby healthy tissues.
Iobenguane (I-131) is a type of molecule that is selectively absorbed by certain types of nervous tissues. This unique characteristic makes it an invaluable tool in diagnosing and treating neuroendocrine tumors. Rhenium-186 isotope takes advanced medical science a step further by the exemplary way its gamma radiation properties enable medical professionals to track its effectiveness in patients with medical imaging technology. Samarium-153 has a dual capacity, its beta particles target and destroy cancer cells, its gamma emissions facilitate imaging and tracking its distribution through the body.
Procedure: Increasing advancements in external beam radiotherapy to streamline process and improve patient comfort
External Beam Radiotherapy (EBRT) is the most typical radiotherapy used to treat various cancers. 3D conformal radiotherapy effectively treats many types of cancers and is well-regarded for its precision and ability to minimize side effects. Image-guided Radiotherapy (IGRT) is an advanced form of radiotherapy involving imaging techniques during treatment delivery. Intensity-modulated Radiotherapy (IMRT) allows the radiotherapy beam to be optimized to the tumor's shape, allowing differing degrees of radiation intensity to various parts of the cancer. Particle therapy uniquely uses charged atomic particles, providing a low dose to the tissues they pass through and then depositing their energy at a precise point. Stereotactic therapy allows for high-dose delivery, particularly to small, well-defined tumors in the brain and other sites, while minimizing the radiation to adjacent normal tissues, thus mitigating potential side effects. Instillation radiotherapy involves injecting a radioactive substance directly into a body cavity or the bladder to treat superficial cancers. Brachytherapy is radiotherapy where the radioactive source is placed inside or next to the tumor, ensuring high-dose radiation while sparing healthy tissues. High-dose-rate (HDR) brachytherapy aims to destroy cancer cells while minimizing the exposure and damage to surrounding healthy tissues. LDR brachytherapy has been extensively used for treating numerous types of cancers, including cervical, prostate, and eye cancer. Pulsed-dose-rate (PDR) brachytherapy involves temporally confined radiation delivery cycles where radiation is emitted in pulses, usually once per hour. This technique seeks to maximize the tumor's dose delivery while safeguarding the surrounding healthy tissue. Intravenous Radiotherapy involves administering liquid radioactive substances into the body via a vein. This treatment is typically used for cancers that have spread or metastasized. Oral Radiotherapy involves ingesting radioactive substances through a pill or liquid. Notable for treating conditions such as thyroid cancer. Systemic radiotherapy uses radiopharmaceuticals that circulate throughout the body, ideal for treating cancers that have spread to bones or multiple sites.
Application: Growing application of radiotherapy for gynecological cancer
Radiotherapy plays a substantial role in breast cancer treatment, substantially reducing the reoccurrence risk within the breast area after surgery. Cervical cancer treatment frequently incorporates radiotherapy either alone or combined with chemotherapy. The need for radiotherapy heavily relies on the cancer stage and localization. Radiotherapy for colorectal cancer treatment is used before surgery to shrink the tumor and after the surgery to kill the remaining cells. Radiation therapy is commonly used to treat various types of gynecological cancers. Depending upon the type and stage of the cancer, radiation is used as primary therapy, adjunctive therapy, or palliative therapy. Radiotherapy is crucial in managing head and neck cancers, often in conjunction with surgery and chemotherapy. Radiotherapy for lung cancer serves as a primary mode of treatment. Penile cancer, although rare, often uses radiation therapy as a primary or supplementary treatment. Radiotherapy is very effective in curative treatment of localized prostate cancer. In comparison, radiotherapy is mostly used for gynecological cancer as it results in local control and survival with few complications.
End-User: Significant role of radiotherapy for hospitals service as they provide comprehensive care for cancer patients
Hospitals provide comprehensive care for cancer patients, including diagnostic and therapeutic services. The offering of radiotherapy as an integrated service within the hospital setting allows for better coordination of care, leading to improved patient outcomes. Independent radiotherapy centers are specialized clinics that offer radiation therapy to cancer patients. These centers provide patients with more personalized and convenient care. While these entities may offer a partial range of services, hospitals can often provide radiotherapy treatment more efficiently and patient-centeredly. Hospitals typically have a broader range of services, enabling them to provide holistic care, drawing patients dealing with multiple health issues. On the other hand, independent radiotherapy centers offer a more patient-centric approach, preferred by patients only seeking radiotherapy.
Regional Insights
The adoption of radiotherapy in the Americas is driven by various factors, primarily increasing cancer prevalence rates and a general preference for non-invasive treatment methods. Advanced technologies such as 3D conformal radiotherapy (3D CRT) and intensity-modulated radiotherapy (IMRT) contribute to this market's growth. Simultaneously, government initiatives focusing on cancer prevention and control are a significant factor behind this market's expansion. EMEA region has an increasing need for radiotherapy due to rising cancer incidents. With diverse cancer cases observed across the region, radiotherapy becomes a preferred treatment solution, offering targeted and efficient treatment outcomes. Regulatory approvals for innovative radiotherapy devices, the proliferation of cancer research, and robust healthcare frameworks further bolster the market. The APAC region is witnessing a rapid expansion in the radiotherapy market driven by the escalating burden of cancer. Several countries have high cancer rates, fueling the need for effective treatment modalities, including radiotherapy. The sector's growth is amplified by increasing awareness about early diagnosis, improved access to cancer treatments, and technological advancements within this domain. APAC's emerging economies are also investing heavily in healthcare infrastructure, which further propels the adoption of radiotherapy.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Radiotherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiotherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Charles River Laboratories International, Inc., Elekta AB, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., IBA Dosimetry GmbH, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., PerkinElmer, Inc., Qfix, Quanterix Corporation, Radiology Oncology Systems, Siemens AG, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Radiotherapy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiotherapy Market?
3. What are the technology trends and regulatory frameworks in the Radiotherapy Market?
4. What is the market share of the leading vendors in the Radiotherapy Market?
5. Which modes and strategic moves are suitable for entering the Radiotherapy Market?